Alva Health

Executive Summary

Alva Health is a privately held digital health and neuroscience company based in Dallas, TX and New Haven, CT, founded in 2018. The company addresses the significant public health challenge of stroke, noting that 1 in 3 US adults have at least one stroke risk factor and approximately 700,000 ischemic strokes occur annually. While specific product details are limited, Alva Health appears to be developing a solution for stroke risk assessment or early detection, leveraging digital health technologies to improve outcomes and reduce the burden of stroke. The company operates in a large and growing market, with stroke being a leading cause of disability and mortality. Despite the lack of publicly disclosed funding or valuation, Alva Health's focus on a critical healthcare need positions it as a potential player in the digital stroke management space. Further information on its technology, regulatory pathway, and commercial strategy would be necessary to fully assess its potential.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance or CE Mark for Stroke Detection Device55% success
• Q3 2026Series A Funding Round Announcement60% success
• Q1 2027Clinical Study Results for Risk Assessment Algorithm50% success